About
Overview
Leadership
The A-team
BOD
Advisors
Investors
Contact
Science
Approach
AKT-driven cancers
KRAS-driven cancers
Pipeline
Overview
ALTA2618: AKT1 E17K
ALTA3263: KRAS
News
Careers
Overview
Mission & values
Benefits
Open positions
Corporate responsibility
Mysterious OrbiMed-backed biotech nears $100M in funding, hints at plans to go after ‘undruggable 3.0’
Contact us
Alterome Therapeutics
13480 Evening Creek Drive North
Suite 450
San Diego, CA 92128
General information
info@alterome.com
Clinical trials
clinical.trials@alterome.com
© 2026 Alterome Therapeutics.
All rights reserved.